H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications
- 24 July 2019
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 144 (3) , 433-443
Abstract
Multiple studies have reported the loss of trimethylation at lysine (K) 27 on histone 3 (H3K27me3) in high-grade malignant peripheral nerve sheath tumors (MPNSTs). However, the diagnostic potential of this finding in MPNSTs remains yet to be fully substantiated. Correspondingly, our aim was to pool systematically-identified metadata in the literature and substantiate the incidence of H3K27me3 loss in this setting.Keywords
This publication has 39 references indexed in Scilit:
- The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expressionGenes & Development, 2013
- Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problemsActa Neuropathologica, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor OutcomeAnnals of Surgery, 2009
- Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerationsJournal of Surgical Oncology, 2008
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Radiation‐induced malignant and atypical peripheral nerve sheath tumorsAnnals of Neurology, 1980
- Transformations Related to the Angular and the Square RootThe Annals of Mathematical Statistics, 1950